00853.HK
MicroPort Scientific Corporation
HKSE · Healthcare · Medical - Devices · CN
HKD 6.08
+0.00%Year over year
Reported trailing growth
- Revenue
- -3.4%
- EBITDA
- +274.9%
- EBIT
- —
- EPS
- +120.6%
- Free cash flow
- +70.6%
- Operating cash flow
- +193.3%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +5.8%
- EBITDA
- +296.1%
- EBIT
- +58.8%
- Net income
- +122.7%
- EPS
- +121.4%
- Free cash flow
- +50.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025